Advanced Search
WANG Yan, ZHANG Zixiong, DAI Mengyuan, TAO Zezhang, XIAO Bokui, CHEN Shiming. Effect of 5-Azacytidine on hTERT mRNA Expression and Telomerase Activity in Human Nasopharyngeal Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2016, 43(1): 6-10. DOI: 10.3971/j.issn.1000-8578.2016.01.002
Citation: WANG Yan, ZHANG Zixiong, DAI Mengyuan, TAO Zezhang, XIAO Bokui, CHEN Shiming. Effect of 5-Azacytidine on hTERT mRNA Expression and Telomerase Activity in Human Nasopharyngeal Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2016, 43(1): 6-10. DOI: 10.3971/j.issn.1000-8578.2016.01.002

Effect of 5-Azacytidine on hTERT mRNA Expression and Telomerase Activity in Human Nasopharyngeal Carcinoma Cells

More Information
  • Received Date: March 12, 2015
  • Revised Date: May 17, 2015
  • To investigate the effect of 5-Azacytidine (5-Aza-C) on subtelomeric region D4Z4 repeats methylation, hTERT mRNA expression and telomerase activity in nasopharyngeal carcinoma (NPC) cell lines in vivo. Methods NPC cell lines CNE, CNE1, CNE2 and 5-8F were treated for 72h with 0, 1, or 2.5μmol/L of the demethylation agent 5-Aza-C. The methylation level of subtelomeric region D4Z4 repeats was evaluated with methylation-specific polymerase chain reaction(MSP); the human telomerase catalytic subunit (hTERT) mRNA expression was assayed by reverse transcription-polymerase chain reaction(RTPCR); the telomerase activity was detected using a telomeric repeat amplification protocol(TRAP) assay. Results Treatment with 5-Aza-C significantly decreased DNA methylation levels at the subtelomeric region D4Z4 repeats, and the degree of demethylation was statistically different from those before treatment. The telomerase activity was greatly reduced and the hTERT mRNA expression was strongly repressed in four NPC cells treated with 2.5μmol/L 5-Aza-C. Conclusion Abnormality of DNA methylation at the subtelomeric region plays a role in the development of NPC. 5-Aza-C could inhibit telomerase activity by downregulating hTERT mRNA expression in NPC cell lines. Detection of the association of hTERT expression with subtelomeric CpG methylation would provide better understanding of the role of subtelomeric structural chromosomal abnormality in NPC.
  • [1]
    Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology[J]. Nat Med, 2011, 17(3): 330-9.
    [2]
    De Carvalho DD, Sharma S, You JS, et al. DNA methylation screening identifies driver epigenetic events of cancer cell survival[J]. Cancer Cell, 2012, 21(5): 655-67.
    [3]
    Pa t r a SK, Be t tuz z i S. Epigene t i c DNA- ( cytos ine -5- carbon) modifications: 5-Aza-2’-deoxycytidine and DNAdemethylation[ J] Biochemistry (Mosc), 2009, 74(6): 613-9.
    [4]
    Passweg JR, Pabst T, Blum S, et al. Azacytidine for acute myeloid leukemia in elderly or frail patients: a phaseⅡtrial (SAKK 30 /07)[J]. Leuk Lymphoma, 2014, 55(1): 87-91.
    [5]
    Strati P, Kantarjian H, Ravandi F, et al. Phase Ⅰ/Ⅱ trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome[J]. Am J Hematol, 2015, 90(4): 276-81.
    [6]
    Low KC, Tergaonkar V. Telomerase: central regulator of all of the hallmarks of cancer[J]. Trends Biochem Sci, 2013, 38(9): 426-34.
    [7]
    Mocellin S, Pooley KA, Nitti D. Telomerase and the search for the end of cancer[J]. Trends Mol Med, 2013, 19(2): 125-33.
    [8]
    Lamy E, Goetz V, Erlacher M, et al. hTERT: another brick in the wall of cancer cells[J]. Mutat Res, 2013, 752(2): 119-28.
    [9]
    M Daniel, Peek GW, Tollefsbol TO. Regulation of the human catalytic subunit of telomerase (hTERT)[J]. Gene, 2012, 498(2): 13 5-46.
    [10]
    Schoeftner S, Blasco MA. Chromatin regulation and non-coding RNAs at mammalian telomeres[J].Semin Cell Dev Biol, 2010, 21 (2): 186-93.
    [11]
    Ng LJ, Cropley JE, Pickett HA, et al. Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription[J]. NucleicAcids Res, 2009, 37(4): 1152-9.
    [12]
    Wang Y, Duan HG, Chen SM, et al. Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein expression in nasopharyngeal carcinoma cells[J]. J Laryngol Otol, 2007, 121(5): 476-82.
    [13]
    Worsham MJ, Chen KM, Meduri V, et al. Epigenetic events of disease progression in head and neck squamous cell carcinoma[J]. Arch Otolaryngol Head Neck Surg, 2006, 132(6): 668-77.
    [14]
    Hutajulu SH, Indrasari SR, Indrawati LP, et al. Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population[J]. Molecular Cancer, 2011, 10(48): 1-9.
    [15]
    Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma[J]. Cancer Epidemiol Biomarkers Prev, 20 06, 15(10): 1765-5.
    [16]
    Li LL, Shu XS, Wang ZH, et al. Epigenetic disruption of cell signaling in nasopharyngeal carcinoma[J]. Chin J Cancer, 2011, 30 (4): 231-9.
    [17]
    Loyo M, Brait M, Kim MS, et al. A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma[J]. J Cancer, 20 11, 128(6): 1393-403.
    [18]
    Saito M, Nishikawa J, Okada T, et al. Role of DNA methylation in the development of Epstein-Barr virus associated gastric carcinoma[J]. J Med Viol, 2013, 85(1): 121-7.
    [19]
    Bechter OE, Eisterer W, Dlaska M, et al. CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia[J]. Exp Hematol, 2002, 30 (1): 26-33.
    [20]
    Kitagawa Y, Kyo S, Takakura M, et al. Demethylating reagent 5- azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT[J]. Clin Cancer Res, 2000, 6(7): 2868-75.
    [21]
    Dessain SK, Yu H, Reddel RR, et al. Methylation of the human telomerase gene CpG island[J]. Cancer Res, 2000, 60(3): 537-41.
    [22]
    Zhang X, Li B, de Jonge N, et al. The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression[J]. Oncotarget, 2015, 6( 7): 4888-900.

Catalog

    Article views (1146) PDF downloads (650) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return